CLEVIPREX
CLEVIPREX
Approved
DIN Number
02366223
Drug Class
Human
Market Date
Aug 4, 2023
Company
HC
CHIESI FARMACEUTICI S.P.A.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02366223
AIG Number0152890001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C08CA16 clevidipine
Product Specifications
Dosage FormEmulsion
Route of AdministrationIntravenous
AHFS Classification24:28.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
CLEVIDIPINEActive
Strength: 0.5 MG / ML
Monograph: CLEVIDIPINE